{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:02:51Z","timestamp":1788796971701,"version":"build-2803163510"},"reference-count":209,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The World Journal of Biological Psychiatry"],"published-print":{"date-parts":[[2015,4,3]]},"DOI":"10.3109\/15622975.2015.1009163","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T10:33:53Z","timestamp":1427711633000},"page":"142-170","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":124,"title":["World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation"],"prefix":"10.1080","volume":"16","author":[{"given":"Alkomiet","family":"Hasan","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wobrock","sequence":"additional","affiliation":[{"name":"Centre of Mental Health, Darmstadt-Dieburg Clinics","place":["Gro\u00df-Umstadt, Germany"]},{"name":"Department of Psychiatry and Psychotherapy, Georg-August-University","place":["Goettingen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lieberman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, Lieber Center for Schizophrenia Research","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"Glenth\u00f8j","sequence":"additional","affiliation":[{"name":"Center for Neuropsychiatric Schizophrenia Research & Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Copenhagen University Hospital, Psychiatric Center Glostrup","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner F.","family":"Gattaz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Sao Paulo","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Thibaut","sequence":"additional","affiliation":[{"name":"University Hospital Cochin-Tarnier, Faculty of Medicine Paris Descartes, INSERM U 894, Centre Psychiatry and Neurosciences","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the WFSBP Task Force on Treatment Guidelines for Schizophrenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,3,30]]},"reference":[{"issue":"3","key":"e_1_3_2_2_1","first-page":"105","article-title":"Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia","volume":"43","author":"Abuzzahab FS","year":"1982","unstructured":"Abuzzahab FS Sr, Zimmerman RL. 1982. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia. J Clin Psychiatry 43(3):105\u2013110.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200202000-00004"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05258gre"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674379804300810"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000270079.84758.fe"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427452"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00164-0"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.08.023"},{"issue":"4","key":"e_1_3_2_10_1","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia","volume":"154","author":"APA","year":"1997","unstructured":"APA. 1997. Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association. Am J Psychiatry 154(4 Suppl):1\u201363.","journal-title":"American Psychiatric Association. Am J Psychiatry"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.188.5.439"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.01118.x"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp001"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970802465807"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970802456590"},{"issue":"2","key":"e_1_3_2_16_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-004-1801-2","article-title":"Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period","volume":"175","author":"Barak Y","year":"2004","unstructured":"Barak Y, Mirecki I, Knobler HY, Natan Z, Aizenberg D. 2004. Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period. Psychopharmacology (Berlin) 175(2):215\u2013219.","journal-title":"Psychopharmacology (Berlin)"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110391123"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.03.022"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2009.03.007"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.10.1706"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c6325"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291714000208"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291701003889"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00065-6"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.7.674"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.191.51.s140"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.177.6.516"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.8.1494"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.6.502"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp116"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn135"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.07.018"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/16.4.571"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11r07410"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.09.001"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709990344"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.01.044"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111408461"},{"issue":"1","key":"e_1_3_2_39_1","first-page":"52","article-title":"Physical illness in patients with severe mental disorders","volume":"10","author":"De Hert M","year":"2011","unstructured":"De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. 2011. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10(1):52\u201377.","journal-title":"I. Prevalence, impact of medications and disparities in health care. World Psychiatry"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(00)00003-7"},{"key":"e_1_3_2_41_1","unstructured":"DGBS\/DGPPN. 2014. S3-Leitlinie zur Diagnostik und Therapie Bipolarer St\u00f6rungen. Langversion 2012. http:\/\/www.dgppn.de\/publikationen\/leitlinien\/leitlinien10.html"},{"key":"e_1_3_2_42_1","unstructured":"DGPPN. 2006. S3 Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1 \u2013 Behandlungsleitlinie Schizophrenie. Darmstadt: Steinkopff-Verlag. http:\/\/www.dgppn.de\/publikationen\/leitlinien\/leitlinien10.html"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000017"},{"issue":"2","key":"e_1_3_2_44_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","article-title":"Drug abuse in schizophrenic patients: clinical correlates and reasons for use","volume":"148","author":"Dixon L","year":"1991","unstructured":"Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. 1991. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148(2):224\u2013230.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_45_1","article-title":"Guideline Watch (September 2009): Practice Guideline for the Treatment of Patients With Schizophrenia","author":"Dixon L","year":"2009","unstructured":"Dixon L, Perkins D, Calmes C. 2009. Guideline Watch (September 2009): Practice Guideline for the Treatment of Patients With Schizophrenia. American Psychiatric Association. http:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/schizophrenia-watch.pdf","journal-title":"American Psychiatric Association"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.06.001"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2009.07.013"},{"issue":"4","key":"e_1_3_2_48_1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/ajp.142.4.499","article-title":"Suicide attempts associated with akathisia","volume":"142","author":"Drake RE","year":"1985","unstructured":"Drake RE, Ehrlich J. 1985. Suicide attempts associated with akathisia. Am J Psychiatry 142(4):499\u2013501.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033429"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-996-0037-8"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.2975\/27.2004.360.374"},{"issue":"2","key":"e_1_3_2_52_1","first-page":"249","article-title":"Thioridazine improves affective symptoms in schizophrenic patients","volume":"29","author":"Dufresne RL","year":"1993","unstructured":"Dufresne RL, Valentino D, Kass DJ. 1993. Thioridazine improves affective symptoms in schizophrenic patients. Psychopharmacol Bull 29(2):249\u2013255.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000351878.45260.94"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017002010"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181f5a5f9"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3182a8ea04"},{"key":"e_1_3_2_57_1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ajp.159.2.323","article-title":"Clozapine and suicide","volume":"159","author":"Ertugrul A","year":"2002","unstructured":"Ertugrul A. 2002. Clozapine and suicide. Am J Psychiatry 159(2):323; author reply 324.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970510030090"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970500483177"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2008.10.006"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-0326"},{"key":"e_1_3_2_62_1","first-page":"D005377","article-title":"Atypical antipsychotics for people with both schizophrenia and depression","volume":"1","author":"Furtado VA","year":"2008","unstructured":"Furtado VA, Srihari V. 2008. Atypical antipsychotics for people with both schizophrenia and depression. Cochrane Database Syst Rev (1):CD005377.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614522682"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048670903487217"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0421"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn107"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181a443d0"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0513"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318295fe12"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/20.2.327"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.3726"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.739708"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.696143"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1579"},{"issue":"9","key":"e_1_3_2_75_1","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1176\/ajp.154.9.1235","article-title":"Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia","volume":"154","author":"Heila H","year":"1997","unstructured":"Heila H, Isometsa ET, Henriksson MM, Heikkinen ME, Marttunen MJ, Lonnqvist JK. 1997. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry 154(9):1235\u20131242.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010385114289"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.05.015"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02291740"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1177\/1359786810385490"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00261-4"},{"key":"e_1_3_2_81_1","first-page":"D001088","article-title":"Psychosocial interventions for people with both severe mental illness and substance misuse","volume":"10","author":"Hunt GE","year":"2013","unstructured":"Hunt GE, Siegfried N, Morley K, Sitharthan T, Cleary M. 2013. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 10:CD001088.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_82_1","unstructured":"IPAP. The International Psychopharmacology Algorithm Project [Internet]. Available from: http:\/\/www.ipap.org\/index.php"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105051542"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.20017"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000053"},{"issue":"3","key":"e_1_3_2_86_1","first-page":"4","article-title":"The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia","volume":"61","author":"Keck PE","year":"2000","unstructured":"Keck PE Jr, Strakowski SM, McElroy SL. 2000. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. J Clin Psychiatry 61(Suppl 3):4\u20139.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.04.027"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.09.010"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.4.366"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.9.1449"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.07.005"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000204137.82298.06"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00054-1"},{"key":"e_1_3_2_94_1","unstructured":"Kishi T Iwata N. 2014. Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014 Nov 8. [Epub ahead of print]. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25283510"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-145"},{"issue":"3","key":"e_1_3_2_96_1","first-page":"308","article-title":"Antipsychotic drugs and breastfeeding","volume":"10","author":"Klinger G","year":"2013","unstructured":"Klinger G, Stahl B, Fusar-Poli P, Merlob P. 2013. Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev 10(3):308\u2013317.","journal-title":"Pediatr Endocrinol Rev"},{"key":"e_1_3_2_97_1","first-page":"D008121","article-title":"Second-generation antipsychotics for major depressive disorder and dysthymia","volume":"12","author":"Komossa K","year":"2010","unstructured":"Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S. 2010. Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst Rev (12):CD008121.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/23.2.195"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(97)03076-X"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp130"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094788"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1007"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.10.014"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2010.12.3\/mlambert"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024597"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000069"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1047"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2014.05.021"},{"issue":"2","key":"e_1_3_2_109_1","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman AF","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. 2004. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 161(2 Suppl):1\u201356.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"e_1_3_2_110_1","first-page":"429","article-title":"How effective are second-generation antipsychotic drugs?","volume":"14","author":"Leucht S","year":"2009","unstructured":"Leucht S, Arbter D, Engel RR, Kissling W, Davis JM. 2009a. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry 14(4):429\u2013447.","journal-title":"A meta-analysis of placebo-controlled trials. Mol Psychiatry"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61764-X"},{"issue":"5","key":"e_1_3_2_112_1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0033-1335405","article-title":"Pharmacological treatment of schizophrenia","volume":"81","author":"Leucht S","year":"2013","unstructured":"Leucht S, Heres S, Kissling W, Davis JM. 2013. Pharmacological treatment of schizophrenia. Fortschr Neurol Psychiatr 81(5):e1\u201313.","journal-title":"Fortschr Neurol Psychiatr"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01388.x"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0206"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-009-0068-3"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1177\/07067437070526S106"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161212802884627"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-7-S1-S312"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(98)00090-6"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000144894.37611.0a"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1080\/00048670601172798"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.2.323-a"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-996-0047-6"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0417"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.1.82"},{"issue":"2","key":"e_1_3_2_126_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.152.2.183","article-title":"Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment","volume":"152","author":"Meltzer HY","year":"1995","unstructured":"Meltzer HY, Okayli G. 1995. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 152(2):183\u2013190.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/23.4.623"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0418"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1980.tb00132.x"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970500316674"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00325-5"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1115"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324480"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S46799"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/16.1.31"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017001713"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e328351a3e0"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.1979.136.4b.574"},{"key":"e_1_3_2_139_1","unstructured":"NICE. NICE clinical guideline 178 \u2013 Psychosis and schizophrenia in adults: treatment and management \u2013 Issued: February 2014 last modified: March 2014 [Internet]. Available from: guidance.nice.org.uk\/cg178"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00370-X"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.181.43.s98"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38133.622488.63"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.113"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.3.247"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001040"},{"issue":"4","key":"e_1_3_2_146_1","first-page":"880","article-title":"Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn","volume":"105","author":"Pediatrics AAo","year":"2000","unstructured":"Pediatrics AAo. 2000. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs. American Academy of Pediatrics. Pediatrics 105(4 Pt 1):880\u2013887.","journal-title":"Committee on Drugs. American Academy of Pediatrics. Pediatrics"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1658-9"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/17.4.649"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-6-10"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.02.005"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2008.03.018"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.03.008"},{"issue":"5","key":"e_1_3_2_153_1","first-page":"569","article-title":"Treatment of secondary depression in schizophrenia","volume":"36","author":"Prusoff BA","year":"1979","unstructured":"Prusoff BA, Williams DH, Weissman MM, Astrachan BM. 1979. Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine. Arch Gen Psychiatry 36(5):569\u2013575.","journal-title":"A double-blind, placebo-controlled trial of amitriptyline added to perphenazine. Arch Gen Psychiatry"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00054"},{"issue":"1","key":"e_1_3_2_155_1","first-page":"1","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders","volume":"39","author":"RANZCP","year":"2005","unstructured":"RANZCP. 2005. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 39(1\u20132):1\u201330.","journal-title":"Aust N Z J Psychiatry"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.12.023"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02251066"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2011.552633"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370605100808"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2013.11.002"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.04.001"},{"key":"e_1_3_2_162_1","doi-asserted-by":"publisher","DOI":"10.1017\/S003329170003467X"},{"issue":"7","key":"e_1_3_2_163_1","article-title":"Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study","volume":"3","author":"Sadowski A","year":"2013","unstructured":"Sadowski A, Todorow M, Yazdani Brojeni P, Koren G, Nulman I. 2013. Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. Br Med J Open 3(7).","journal-title":"Br Med J Open"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033362"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.nmd.0000165089.14736.bf"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01484.x"},{"key":"e_1_3_2_167_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2014.12126.x"},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2012.01897.x"},{"key":"e_1_3_2_169_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.6.931"},{"key":"e_1_3_2_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2011.05.001"},{"key":"e_1_3_2_171_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197009000-00005"},{"key":"e_1_3_2_172_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198308000-00006"},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S12044"},{"key":"e_1_3_2_174_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/16.1.111"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.9.1379"},{"key":"e_1_3_2_176_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500209"},{"key":"e_1_3_2_177_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950020033003"},{"issue":"1","key":"e_1_3_2_178_1","first-page":"127","article-title":"Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients","volume":"29","author":"Siris SG","year":"1993","unstructured":"Siris SG, Mason SE, Bermanzohn PC, Shuwall MA, Aseniero MA. 1993. Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients. Psychopharmacol Bull 29(1):127\u2013133.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700710"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000194624.07611.5e"},{"key":"e_1_3_2_181_1","doi-asserted-by":"publisher","DOI":"10.1159\/000068809"},{"key":"e_1_3_2_182_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02190250"},{"key":"e_1_3_2_183_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979591"},{"key":"e_1_3_2_184_1","doi-asserted-by":"publisher","DOI":"10.2174\/157340410790979716"},{"key":"e_1_3_2_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.08.010"},{"key":"e_1_3_2_186_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1189"},{"key":"e_1_3_2_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60742-X"},{"key":"e_1_3_2_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00049-9"},{"issue":"25","key":"e_1_3_2_189_1","first-page":"51","article-title":"Pharmacologic interventions in suicide prevention","volume":"62","author":"Tondo L","year":"2001","unstructured":"Tondo L, Ghiani C, Albert M. 2001. Pharmacologic interventions in suicide prevention. J Clin Psychiatry 62(Suppl 25):51\u201355.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_2_190_1","first-page":"D007253","article-title":"Interventions for smoking cessation and reduction in individuals with schizophrenia","volume":"2","author":"Tsoi DT","year":"2013","unstructured":"Tsoi DT, Porwal M, Webster AC. 2013. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2:CD007253.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_191_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1214c"},{"key":"e_1_3_2_192_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2850.2005.00903.x"},{"key":"e_1_3_2_193_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770330075006"},{"key":"e_1_3_2_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2006.09.003"},{"key":"e_1_3_2_195_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.11.006"},{"key":"e_1_3_2_196_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317040-00004"},{"key":"e_1_3_2_197_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199711000-00014"},{"key":"e_1_3_2_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2011.06.003"},{"key":"e_1_3_2_199_1","first-page":"D004411","article-title":"Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum","volume":"2","author":"Webb RT","year":"2004","unstructured":"Webb RT, Howard L, Abel KM. 2004. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. Cochrane Database Syst Rev (2):CD004411.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_200_1","doi-asserted-by":"publisher","DOI":"10.2190\/WM5V-D9Y2-2HYW-VGWX"},{"key":"e_1_3_2_201_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291703007645"},{"key":"e_1_3_2_202_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.4.329"},{"key":"e_1_3_2_203_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/23.2.215"},{"key":"e_1_3_2_204_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700019863"},{"issue":"10","key":"e_1_3_2_205_1","first-page":"369","article-title":"Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics","volume":"44","author":"Wistedt B","year":"1983","unstructured":"Wistedt B, Palmstierna T. 1983. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics. J Clin Psychiatry 44(10):369\u2013371.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_2_206_1","doi-asserted-by":"crossref","unstructured":"Wobrock T Guse B Cordes J W\u00f6lwer W Winterer G Gaebel W et al. 2014. Left prefrontal high-frequency rTMS for the treatment of schizophrenia with predominant negative symptoms \u2013 a sham-controlled randomized multicentre trial. Biol Psychiatry advance online publication http:\/\/dx.doi.org\/10.1016\/j.biopsych.2014.10.009","DOI":"10.1016\/j.biopsych.2014.10.009"},{"key":"e_1_3_2_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.02.008"},{"key":"e_1_3_2_208_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181e7810a"},{"issue":"3","key":"e_1_3_2_209_1","first-page":"309","article-title":"Adjunctive desipramine in the treatment of cocaine abusing schizophrenics","volume":"28","author":"Ziedonis D","year":"1992","unstructured":"Ziedonis D, Richardson T, Lee E, Petrakis I, Kosten T. 1992. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics. Psychopharmacol Bull 28(3):309\u2013314.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_2_210_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05699gre"}],"container-title":["The World Journal of Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/15622975.2015.1009163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:54:06Z","timestamp":1772704446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/15622975.2015.1009163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,30]]},"references-count":209,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4,3]]}},"alternative-id":["10.3109\/15622975.2015.1009163"],"URL":"https:\/\/doi.org\/10.3109\/15622975.2015.1009163","relation":{},"ISSN":["1562-2975","1814-1412"],"issn-type":[{"value":"1562-2975","type":"print"},{"value":"1814-1412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iwbp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iwbp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-03-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}